Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review

1477-7517-4-14 1477-7517 Review Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review Islam Md Mofizul mikhokan143@yahoo.com Conigrave M Katherine katec@med.usyd.edu.au

STIRC, the University of Sydney, Sydney, NSW, Australia

Drug Health Services, Royal Prince Alfred Hospital, Sydney, NSW, Australia

Faculty of Medicine, the University of Sydney, Sydney, NSW, Australia

Harm Reduction Journal 1477-7517 2007 4 1 14 http://www.harmreductionjournal.com/content/4/1/14 17958894 10.1186/1477-7517-4-14 05 3 2007 24 10 2007 24 10 2007 2007 Islam and Conigrave; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Reaching hard-to-reach and high-risk injecting drug users (IDUs) is one of the most important challenges for contemporary needle syringe programs (NSPs). The aim of this review is to examine, based upon the available international experience, the effectiveness of syringe vending machines and mobile van/bus based NSPs in making services more accessible to these hard-to-reach and high-risk groups of IDUs. A literature search revealed 40 papers/reports, of which 18 were on dispensing machines (including vending and exchange machines) and 22 on mobile vans. The findings demonstrate that syringe dispensing machines and mobile vans are promising modalities of NSPs, which can make services more accessible to the target group and in particular to the harder-to-reach and higher-risk groups of IDUs. Their anonymous and confidential approaches make services attractive, accessible and acceptable to these groups. These two outlets were found to be complementary to each other and to other modes of NSPs. Services through dispensing machines and mobile vans in strategically important sites are crucial elements in continuing efforts in reducing the spread of HIV and other blood borne viruses among IDUs.

Introduction

HIV transmission associated with sharing of contaminated injecting equipment is now a global problem, with more than 110 countries having reported HIV transmission in this context 1. World Health Organisation (WHO) estimates approximately 10% of all new HIV infections globally can be attributed to the sharing of contaminated injecting equipment 2. In many parts of the world injecting drug users (IDUs) comprise a far higher proportion of new HIV infections, for example 72% of new HIV infections in Ukraine 3. An injecting drug user infected with HIV can cause a cascade of new infections in other individuals, not only through sharing of contaminated injecting equipment but also through sexual and perinatal transmission. Hepatitis C and B, two other blood-borne viruses, are far more easily transmitted by blood-blood contact than HIV 45 and carry the risk of cirrhosis.

Having experienced the limited outcomes of efforts to significantly eliminate supply and demand for illicit drugs by law enforcement, and in the face of rising prevalence of HIV and other blood-borne viruses, there has been a growing urgency to implement more effective prevention responses to prevent transmission of blood-borne viruses among IDUs. Therefore, authorities have adopted a more realistic approach to drug policy, termed as 'Harm Reduction' or 'Harm minimisation' in which reduction of adverse consequences of drug use is valued as high priority at least as important as reducing demand and supply. The Needle Syringe Program (NSP) or Needle Exchange Program (NEP) is a fundamental component of harm reduction that supports access to sterile injecting equipment for IDUs and discourages sharing of used injecting equipment. Preventive measures through NSP will remain the most effective tool available to reduce the spread of HIV among and from IDUs until an effective and widely deployed vaccine is available.

NSP disease prevention efforts are dependent in part on their ability to attract and maintain contact with IDUs so that injecting equipment, and also education and referrals can be provided. However, IDUs often avoid service providers until a crisis emerges, because they perceive interactions in service settings can be embarrassing, degrading, unhelpful and can be offered at locations and times incompatible with their lives 6. To overcome these difficulties, a variety of measures have been developed to improve access to and utilization of sterile injecting equipment, and to increase choice for users. These include several methods for distribution, sale or exchange of injecting equipment such as conventional NSPs (housed in a fixed location where IDUs are attended by health staff), pharmacy-based distribution or exchange, dispensing machines (that either sell injecting equipment, provide it for free or in exchange for used equipment) and outreach programmes – often using a mobile van or bus and sometimes through home-visits. In addition, health education and safer injecting advice has been provided. Services through dispensing machines and mobile vans have been reported to be responsive to a wider range of IDUs and most importantly to hidden and harder-to-reach IDUs in the community, who for several reasons do not or cannot attend conventional NSPs 78. The aim of this review is to examine the available evidence for the effectiveness of syringe dispensing machines and mobile van or bus based NSPs in making services accessible to hard-to-reach and high-risk groups of IDUs.

Methods

Journal publications, conference presentations and proceedings, evaluation reports, and other relevant organizational reports relating to supply of sterile injecting equipment through dispensing machines and/or mobile vans were identified by a comprehensive search of electronic databases such as Medline, Medscape, Current Contents, HealthSTAR, CAB Abstracts, Aidsline, Sociological Abstracts and CINAHL. In addition, experts involved with development and evaluation of current programs or policy were contacted for official reports, policy documents or unpublished materials. In total, 40 papers/reports were found that primarily focused on dispensing machines and/or mobile vans, of which 18 focused on dispensing machines and 22 on mobile vans.

Results

Introduction of dispensing machines and mobile vans to NSP

Syringe dispensing machines were first introduced in Copenhagen, Denmark in June 1987 9 then a few months later in Larvik, Norway. Subsequently they were introduced in several European countries including Switzerland, Germany, France, Italy, the Netherlands, Austria, and also in Australia and New Zealand. These are automatic commercial dispensing machines that exchange new for used syringes, or provide sterile equipment for a coin or free-of-cost. These machines are also known as 'syringe exchange machines', 'syringe vending machines', 'syringe automat' or 'FITPACK^®vending machines' (in Australia), 'electronic dispenser', 'distribox^®' or sometimes simply 'slot machines'. New Zealand introduced a mobile dispensing machine which is wheeled to a front doorway and locked there. This design enables exchange services to continue after hours in a safer way 10.

The NSP-mobile van was first introduced one year earlier, in 1986, in Amsterdam, the Netherlands. It was, in fact, a methadone dispensing bus that also offered syringe and needle exchange 11. In the same year health workers in London and Liverpool started to exchange needles and syringes using mobile vans 12. In some settings this form of NSP is known as a 'roving van' or 'mobile bus' or simply 'mobile outlet'. Mobile vans have received much more acceptance than dispensing machines and have been introduced more widely.

The rationale for dispensing machines and mobile vans in NSPs

Each of these approaches offers the potential to provide injecting equipment to hard-to-reach and high-risk groups of IDUs. For example, some IDUs are concerned to remain anonymous and fear that they may be identified if they try to access sterile injecting equipment from pharmacies or conventional NSPs 131415. Many IDUs need access to services in the evening, at night or in weekends. These users strongly feel the need for a non-contact and out of business hours service and consequently dispensing machines were introduced to supply sterile needles and syringes together with condoms, health information pamphlets and other minor health supplies 16. Dodding & Gaughwin 17 reported that one of the main reasons identified by Australian IDUs for sharing injecting equipment was the relative unavailability of sterile injecting equipment, particularly outside the operating times of pharmacies and conventional NSPs. If attempts are made to continue conventional NSPs at nights and weekends, staffing may be difficult or expensive and also staff may see the work as risky. Dispensing machines overcome these staffing problems. The possibility that judgmental attitudes of some pharmacy staff and NSP staff might discourage some IDUs from obtaining sterile injecting equipment 1819 was another consideration.

Unlike dispensing machines, mobile vans do not provide completely anonymous access to sterile injecting equipment, but peer staffed mobile vans can render a congenial environment that provides near anonymous access. Mobile vans can cover a greater geographic area and can more readily accommodate changes in local conditions. A van of this sort generally follows a relatively consistent route, and parks at a predictable location at a predictable time, although it can change in response to immediate neighbourhoods' conditions (e.g., increased police presence) or to incorporate additional populations of injecting drug users. One van may visit multiple sites in a single outing. It can provide the benefits of both a fixed and a mobile site. In addition, it can also provide shelter and some security for staff, some privacy for clients, and a consistent service while covering a large geographic area. A roving site also keeps staff members and clients relatively inconspicuous to neighbours, local business people, and police officers.

Reaching hidden and hard-to-reach IDUs

A subgroup of IDUs are largely marginalised, isolated and socially excluded and highly mobile54. They are often not in contact with any services, as they are either unaware of them or do not wish to access them. Corr 54 characterised these groups as drug users who are mostly homeless, female, younger, chaotic and from an ethnic minority. Prisoner IDUs form another important high-risk group. Beginner-IDUs are also hard-to-reach and usually do not define themselves as drug addicts and do not approach NSPs or drug treatment units. None of these groups are mutually exclusive and when these characteristics are multiplied in the same individual, the person is likely to suffer increasing marginalisation 55. They are highly susceptible to potential adverse health outcomes, particularly blood-borne virus infections as their risky behaviours often go unrecognized. Of the studies/reports reviewed, 37 presented data/results on the ability of dispensing machines and/or mobile vans to reach hidden and hard-to-reach IDUs (Table 1).

Table 1

Ability of NSP-mobile vans and dispensing machines to reach high-risk and/or hidden IDUs.

Syringe dispensing machines

Mobile vans

Ref.

Location

Reached high-risk and/or hidden IDUs

Ref.

Location

Reached high-risk and/or hidden IDUs

[20]

Vestfold, Norway

Yes

[21]

Paris, France

Yes

[22]

Rotterdam, the Netherlands

Yes

[23]

Paris, France

Yes

[24]

Milan, Italy

Yes

[25]

Geneva, Switzerland

[26]

Sydney, Australia

Yes

[27]

Rome, Italy

Yes

[28]

Berlin, Germany

Yes

[29]

Spain

Yes

[30]

Berlin, Germany

Yes

[31]

Rockville, USA

Yes

[32]

New South Wales, Australia

Yes

[33]

Vancouver, Canada

Yes

[17]

Perth and Adelaide, Australia

Yes, it will*

[34]

Wisconsin, USA

Yes

[35]

Hindelbank, Switzerland

Yes

[36]

Baltimore, USA

Yes

[37]

Realta, Switzerland

Yes

[38]

Sicily, Italy

Yes

[39]

Marseille, France

Yes

[8]

Baltimore, USA

Yes

[40]

Vechta, Germany

Yes

[41]

St. Petersburg, Russia

Yes

[42]

Kalgoorlie, Australia

Yes

[43]

Oslo, Norway

Yes

[9]

Bremen, Germany

[44]

Sofia, Bulgaria

Yes

[45]

Marseille, France

Yes

[46]

Vancouver, Canada

Yes

[47]

Lichtenberg, Lehrter Strasse, Germany

Yes

[48]

Madrid, Valencia and some other places of Spain

Yes

[49]

Hamburg-Vierlande, Germany

[50]

Vilnius, Lithuania

Yes

[51]

New Heaven, CT, USA

Yes

[52]

Canberra, Australia

Yes

[53]

Melbourne, Australia

Yes

* Perception of focus group IDUs and health staff. NM = Not mentioned

Dispensing machines

Few studies have attempted to evaluate whether dispensing machines attract hidden, hard-to-reach or high-risk IDUs. Perhaps the most comprehensive studies were performed in Marseille, France where it was found that primary users of vending machines were significantly younger and less likely to live in a house they personally owned or rented; they were also less likely to have been in opioid maintenance treatment 39. The researchers concluded that the machine outlet seemed to effectively attract a relatively hidden 7 and high-risk segment of IDUs who are less likely to be reached by other programs 39. In the same city Moatti et al. 45 reported that users of vending machines were younger than those who accessed pharmacy or NSP for needle-syringe and tended to have a lower socioeconomic status. They were significantly less likely than pharmacy users to have a regular job, and more likely than NSP users to be without any resources. Stark et al. 30, in their vending machine study in Berlin, found that machines users were more likely to report a shorter history of injection. The authors explained that early in their injection career IDUs may prefer to obtain injecting equipment anonymously from vending machines. They may not yet consider themselves drug dependent, and may not be willing to contact staffed agencies. This explanation was supported by their findings that only 33% of the IDUs reported current contacts with counselling units. This rate was significantly lower in those with a shorter history of injecting. Similarly Leicht 28 reported that novice IDUs are the main users of machines with most having no contact with other helping agencies for IDUs'. Based upon the findings of a study in Italy, Agnoletto et al 24 underscored the need for complementary use of both exchange machines and mobile vans to modify risk behaviours of drug users who are not in contact with health services.

Evaluation of dispensing machines in Norway showed that these were a successful method of providing sterile equipment to a group until then difficult to reach 20. Comparable results had also been observed from all the studies in Australia. Dodding & Gaughwin 17 reported that because of the small populations in rural towns, the confidentiality of IDUs in those areas can be particularly important and vending machines may be a valuable form of NSP. Most participants (IDUs and health workers) in this study believed that some IDUs in these areas do not use their local NSPs or pharmacies because of concern for anonymity.

Prisoner-IDUs are at very high risk of blood-borne infections. A range of interlinking factors compound this risk – the large number of IDUs, scarcity of sterile injecting equipment and correspondingly higher prevalence of needle-syringe sharing, rapid turnover of prison populations and hence far more changes in injecting partners 56. Syringe exchange machines were found to be very effective in increasing access to sterile injecting equipment in prisons in Switzerland and Germany. Their easier and round-the-clock access, high-degree of anonymity; better acceptance by inmates and better control of syringe disposal (one-for-one exchange) made these machines a useful mode of syringe exchange. The availability of injecting equipment through dispensing machines did not lead to an increase in drug use or injection frequency and syringe sharing reduced significantly 47. Stöver & Jacob 40 reported that anonymous access through exchange machines in a Women's Prison made it more acceptable to the inmates than manual distribution in a Men's Prison. The authors concluded that the level of acceptance among prisoners largely depended on whether anonymity is maintained during needle exchange. However, unfortunately with political changes, all but one syringe exchange machine in prisons in Germany have been removed. Only Lichtenberg-Berlin still offers syringes.

Mobile vans

Overall findings suggest that mobile van outlets of NSPs are effective in reaching hidden and high-risk group of IDUs. A large study (n = 1020) in Vancouver compared risk taking behaviours of IDUs attending conventional, and mobile van needle exchanges 46. This demonstrated increasing risk profiles from IDUs who attend pharmacy, to those who attend conventional NSPs to mobile exchange van clients. Van users were more likely to be younger, Indigenous and female. These results are consistent with another Vancouver study 33, which compared van to conventional NSP users. Van users were found to inject more frequently, inject more frequently on the street, be younger, more likely to engage in sex work and less likely to be enrolled in a drug treatment program.

Riley et al. 36 studied new clients of both a mobile van and of a pharmacy-based NEP in the same neighbourhood in Baltimore. They found that the van attracted twice as many high-frequency injectors. Similarly, "Blue Bus" exchange in Lithuania reports successfully reaching a particular local community, identified as one of the most at risk groups, where injecting drug use is common. A survey conducted to evaluate the impact of the Blue Bus service on injecting practices of its clients revealed that within the previous 30 days 96% of IDUs reported they did not utilize used syringes, 88% did not share used syringes and needles with others, and 92% said they did not buy syringes already filled with a narcotic 50.

According to official data from the Ministry of Health, less than half the IDUs in Rome were in touch with drug dependence treatment units during 1992. However, with the aid of an outreach mobile van, 1023 (52.5%) new IDUs (who were not attending other services) were provided with services from the van in a one year period during 1992–93 27. Similarly, a mobile van outreach program in Spain encountered 1,745 new clients in only a 9 month period 29. Comparable results have been reported on an evaluation of a pilot program using a camper van in Catania, Sicily. Although the camper van suffered a lack of active support from other drug treatment agencies and organisations, it slowly was able to establish contacts with an increasing number of hidden IDUs 38. Lhomme et al. 21 reported findings of an evaluation of a NEP in Paris, which introduced mobile vans in its second phase. Of those accessing the program, 60% were homeless and 46% HIV positive of whom 59% were without medical follow-up.

Complementary or duplication of services?

As evidence for the ability of these two types of NSP outlets to reach the hidden, hard-to-rich and high-risk group of IDUs has accumulated, it would be hoped that they complement each other and other modes of NSPs. Only two studies are available that have evaluated both dispensing machines and mobile vans. Agnoletto et al. 24 studied IDUs who used exchange machines and/or mobile vans but were not in contact with other health services in Milan, Italy. The authors concluded that the need to provide non-judgemental access to counselling and information justify complementary utilization of both exchange machines and mobile units as strategies for harm reduction. This observation is in keeping with the findings of a Berlin study that found users of vending machines, low-threshold meeting places and needle-exchange buses were significantly different in terms of HIV-rate, history of drug use and contact with counselling units 28. Therefore they are different target groups for HIV-prevention. The most common three recommendations from IDUs (n = 76) interviewed in Scotland to improve access and quality of services were (i) outreach schemes and vending machines (62%), (ii) extending opening hours (12%) and (iii) more privacy in NEP (9%) 57. These findings support the relevance of these two outlets in the context of other modes of NSP.

The most important advantage of dispensing machines is their anonymous and off-peak services when other outlets are closed. The findings of French trials consistently found that these machines are a useful adjunct to other modes of NSPs by reaching a different segment of IDUs 3945. All four evaluations 26324252 and a focus group discussion with IDUs 17 in Australia also supported the complementary role of dispensing machines.

Mobile vans mostly provide a flexible outreach service and act as a bridge to fixed-site outlets. For example, in Volgograd (Russian Federation) a fixed-site is augmented by a bus which serves three networks of drug users who live far apart in the city that stretches 40 km along the Volga river 58. Similarly, Somlai et al. 34 described a mobile service, Lifepoint, which visits a number of high traffic areas on a rotating basis. These areas include drug houses, taverns, parks, and commercial sex areas. The duration of each visit to each site varies according to drug house locations, seasonal migrations of clients during cold weather, and in response to advice from key informants.

In some countries, amidst strong injecting paraphernalia law and few or no dispensing machine outlets on the grounds of importance of health staff contact, the mobile van can reduce the distance for users to travel to get needles and syringes. Carrying used syringes for a long periods in order to exchange presents problems for IDUs in the presence of police pressure and can dissuade them from bringing used syringes back 38. The van reduces the risk of being caught by a law enforcing agency. Burrows 58 reminds us that forced closure is the most common reason for NSPs terminating services, and mobile services are often easier for local residents to cope with and can prevent or overcome the opposition that is focused on a fixed-site NSP. On the other hand, some IDUs in Vancouver mentioned the difficulty in meeting the mobile van as one of the major challenges 59, an issue vending machines may address effectively.

Importantly, while dispensing machines ensure great anonymity, they take away the important contact of IDUs with heath staff. In contrast, mobile vans ensure the contact but reduce anonymity.

Discussion

This review offers evidence to support the notion that dispensing machines and mobile vans can accommodate different patterns of user, diversifying services to meet various needs. Drug use is not confined to a nine-to-five schedule. Practitioner-feedback from the only NSP outlet in Australia that is staffed 24 hours a day and 365 days a year indicates that close to half of the services are provided between 6 pm and 6 am 60. Nevertheless in many parts of the world, even where NSPs are on a strong platform, there are few if any access points to sterile injecting equipment during these hours. In such a context, the need for a 24-hour service is gravely felt and syringe dispensing machines have emerged as a simple and very effective tool.

It is known that bringing users into contact with people who can support and promote appropriate behaviour change is an important aspect of contemporary NSPs 61. This aspect has been valued so strongly in the NSPs of USA that it has probably worked against the introduction of dispensing machines 62. However, it has also been recognised that because of the illicit nature of drug use, some users are reluctant to use services which bring them into contact with anyone, and even the relatively anonymous services provided by local pharmacies 63. For those people a non-contact service was needed and dispensing machines to supply sterile equipment have emerged as an aid to them.

Syringe dispensing machines are likely to be highly cost effective, and the main saving is in staff costs. Clearly the staff costs would be substantial if a 24 hours staffed service is provided. Berg 26 found that machines could be highly self-supporting at lower prices for equipment, and be highly cost-effective even if the equipment was dispensed free-of-cost. However, this cost saving is based only on the cost of provision of sterile equipment and does not take into account the potentially greater health promotion impact via staff-user contact at staffed NSP outlets 64. On the other hand, a mobile van service can be relatively expensive as, in addition to personnel cost, it involves the purchase and maintenance of a vehicle and fuel costs 58.

However, services through mobile vans can be provided at both locations and times that are compatible with the IDUs' lives. Mobile vans increase accessibility for clients who do not have a vehicle or money for transportation, and/or may be too drug-impaired to drive to the fixed-site. The importance of having a service close to IDUs was observed in a study in New York 65. The authors found that 81% of IDUs who lived nearby typically used a NEP compared to 59% of those who lived further away. In multiple logistic regression analysis, those who lived nearby remained 3 times more likely (adjusted OR = 2.89; 95% CI 2.06–4.06) to use NEP, and were less likely to have engaged in receptive syringe sharing at their last injection (adjusted OR = 0.45, 95% CI 0.24–0.86). Therefore, locating NSP services in areas convenient to large numbers of IDUs may be critical for prevention of blood-borne virus infection. It might not always be possible to set up fixed-site NSP in all strategically important points because a range of variables needs to be addressed before attempting to set-up and then make it responsive to the need of IDUs. The mobile van can come to aid in resolving this problem.

Despite having conventional NSPs and pharmacies available, IDUs might experience several barriers in accessing sterile equipment. It was found that those who reported difficulty with accessing sterile needles were 3.5 times more likely to report needle sharing than were people without difficulty 66. Table 2, we developed, describes some common barriers to NSP access, the majority of which were reported in a study in Sydney 67. It also helps us understand the likely ability of dispensing machines and mobile vans to improve the accessibility and acceptability of NSPs to IDUs by addressing several barriers that IDUs encounter with the conventional NSPs and pharmacy outlets.

Table 2

Standard of good practice of dispensing machine and mobile van to address some common barriers experienced by IDUs in accessing sterile injecting equipment from conventional NSPs and pharmacy outlets.

Some common barriers to access

Vending Machines' ability to address

Mobile Vans' ability to address

Worried about being seen as an IDU

Very good

Moderate

Do not feel comfortable to visit NSPs

Very good

Moderate

Worried about being seen by parents/relatives

Moderate

Hours not open when needed

Very good

Moderate

Pharmacies do not want to sell

Very good

Did not like attitudes of pharmacy-staff

Very good

Did not know about NSPs

Very good^α

Too far to travel NSPs or Pharmacies

Very good^α

Did not like location of NSPs or Pharmacies

Very good^α

Very good ^α

Too many police around NSPs

Very good

Not easy to travel to NSP and pharmacy

Very good ^α

NSPs are too busy

Very good

NSP too close to a methadone clinic

Very good ^α

Limited equipment available at once

Very good^β

Very good ^δ

Did not like NSP staff

Very good

Very good ^γ

Did not understand the language

Very good

Moderate

NSPs are male dominated

Very good

Moderate ^Ω

α: If strategically important places are covered by dispensing machines and (or) vans; β: If needle-syringes are offered for coin or free of cost; δ: If not strict to one-to-one exchange; γ: If peer staff are employed; Ω: It may be very good if services are gender responsive.

The results of this review do not support one type of NSP outlet over another, rather they suggest that coexistence of different modes and tailoring of services offered at different venues might be an important consideration. There is a convincing body of international experience on the effectiveness of conventional NSPs in providing access to sterile injecting equipment to IDUs, which in many settings cannot be replaced by other modes 68. Nor on the other hand is it feasible to replace the advantages of a mobile van or dispensing machine by a conventional outlet. Cox et al. 69 recommends comprehensive NSPs including pharmacy involvement in distribution, strategically-placed dispensing machines and mobile exchanges.

This review should be considered in the light of several limitations. Firstly, only literature published in the English language was reviewed. Subsequent reviews should consider translating publications in other languages to capture a greater range of evidence. Secondly, most of the literature originated from developed countries and may not be generalizable to the conditions of developing countries where the vast majority of the world's IDUs now live. Thirdly, there is a paucity of data even in the grey literature. In addition, the articles reviewed may be subject to various biases.

Conclusion

There is persuasive evidence that different venues of NSP attract different clients. In particular, dispensing machines and mobile vans are preferred modalities for hidden and high-risk IDUs. These two modalities can successfully address concerns about temporal and spatial accessibility and overall acceptability of NSP. Intrinsic advantages of each can offset the shortcomings of the other. Despite the relatively small volume of publications a clear and consistent finding is that these two outlets, if set up properly in a well chosen location with the local community well prepared, can generally increase the availability of sterile injecting equipment at times and places where coverage is poor. They also may enhance NSP provision through providing anonymous and confidential access to sterile injecting equipment for hidden and high-risk groups of IDUs.

Statement of competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

MMI conceived of the review, collected the available background articles/reports on this topic and wrote the first draft of the manuscript. KMC critically analysed the manuscripts, corrected and revised all the versions. Both the authors read and approved the final manuscript.

Acknowledgements

The first author gratefully acknowledges the relevant authority of AusAID for awarding him ADS scholarship for Masters Programme. He also acknowledges the Government of Bangladesh for giving him deputation for higher study. He is delighted to acknowledge Dr Richard Hillman of STIRC for his all out assistance in Masters Programme.

The authors gratefully recognise the assistance of Libraries of the University of Sydney.

Harm Reduction Approaches to Injecting Drug Use WHO Retrieved September 2005 2005 http://www.who.int/hiv/topics/harm/reduction/en/ HIV/AIDS Prevention and Control WHO-Regional Office for Southeast Asia Retrieved October 2005 2005 http://w3.whosea.org/EN/Section10/Section18/Section2009_9939.htm Epidemiological Fact Sheet - Ukraine 2004 Update UNAIDS/WHO accessed 10th November 2004 http://www.unaidsorg/en/media/factsheetsasp Hepatitis C: Waiting for the grim reaper Wodak A Medical Journal of Australia 1997 166 284 285 9087180 The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not Crofts N Aitken CK, Kaldor JM Medical Journal of Australia 1999 170 220 221 10092920 Needle Exchange Programs: Delivery and Access Issues Strike CJ Challacombe L, Myers T, Millson M Canadian Journal of Public Health 2002 93 5 339 343 Vending machine enlisted in AIDS fight Berger A New York Times New York 1999 December 28, F7 (col. 1) Drug users participating in mobile needle exchange report higher HIV risk behaviors than those participating in pharmacy-based needle exchange: San Francisco. Riley ED Vlahov D, Safaeian M, Marx MA, Beilenson P, Strathdee S 2000 German towns fund syringe automat for injectors Anonymous Druglink 1989 4 5 6 New Zealand needle and syringe exchange programme review final report Aitken C Wellington , The Center for Harm Reduction 2002 A Review of Harm Reduction Approaches in Ireland and Evidence from the International Literature Moore G McCarthy P, MacNeela P, MacGabhann L, Philbin M, Proudfoot D Dublin , National Advisory Committee on Drugs 2004 Outreach work with drug users: an overview Buning E International Journal of Drug Policy 1993 4 2 78 82 Ways of using: functional injecting drug users’ project Sharp R Davis M, Dowsett GW, Kippax S, Hewitt K, Morgan S, Robertson W Sydney , NSW Health Department 1991 Evaluation of needle exchange pilot projects shows positive results Stöver H Canadian HIV/AIDS Policy & Law Newsletter 2000 5 2/3 60 64 The effectiveness of needle exchange programs: A review of the science and policy Strathdee SA Vlahov D AIDScience 2001 1 16 1 31 Western Australian initiatives to prevent the spread of HIV/AIDS amongst injecting drug users Loxley W Watt P, Kosky M, Westlund B, Watson C, Marsh A International Journal on Drug Policy 1991 2 4 13 16 The Syringe in the machine Dodding J Gaughwin M Australian Journal of Public Health 1995 19 406 409 7578544 Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws Gleghorn AA Gee G, Vlahov D Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998 18 (Suppl 1) S89 S93 Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices Wright-De Agüero L Weinstein B, Jones TS, Miles J Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998 18 (Suppl 1) S102 S110 Reaching the ‘Hard to Reach’: Dublin Castle, Ireland. Corr C 2002 ‘Marginalised Groups’ Starmans R Management of Drug Users in the Community: A Practical Handbook London: Arnold Robertson R 1998 Syringe vending machines for injecting drug users: an experiment in Marseille, France Obadia Y Feroni I, Perrin V, Vlahov D, Moatti JP American Journal of Public Health 1999 89 12 1582 1584 Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France Moatti JP Vlahov D, Feroni I, Perrin V, Obadia Y Eur Addict Res 2001 7 40 45 10.1159/000050713 11316925 Characteristics of users of syringe vending machines in Berlin Stark K Leicht A, Müller R Sozial und Praventivmedizin 1994 39 4 209 216 10.1007/BF01309220 7941771 Characteristics and HIV-infection of users of syringe vending-machines and exchanging programs in Berlin/Germany: Berlin, Germany. Leicht A 1993 Street work and needle exchange machines as complementary strategies of HIV harm reduction among active drug users: an Italian model (Abstract no. WS-D09-4): Berlin, Germany. Agnoletto V Tradati C, Ceserani N, Capra E, Andolina P, Lesomo C 1993 8278775 The syringe dispenser project in Larvik: Experience after one year. (Abstract, PMID: 2595707) Diseth TH Tidsskr Nor Laegeforen 1989 109 32 3345 3348 2595707 Prison-based syringe exchange programmes: a review on international research and development Dolan K Rutter S, Wodak A Addiction 2003 98 153 158 10.1046/j.1360-0443.2003.00309.x 12534419 Ten years of experience with needle and syringe exchange programmes in European prisons Stöver H Nelles J International Journal of Drug Policy 2003 14 437–444 10.1016/j.drugpo.2003.08.001 The transfer of harm-reduction strategies into prisons: needle exchange programmes in two German prisons Stöver H Jacob J International Journal of Drug Policy 2000 11 325 335 10.1016/S0955-3959(00)00050-5 10967515 Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites and mobile van needle exchanges Miller CL Tyndall M, Spittal P, Li K, Palepu A, Schechter MT Journal of Urban Health 2002 79 2 257 265 12023501 Maximizing needle exchange coverage among injection drug users (IDUs): do mobile programs attract those at highest risk?: Geneva, Switzerland. Schechter M Currie S, Strathdee SA, O'Shaughnessy MV, Patrick DM, Rekart ML, Turvey J, Schechver MT 1998 Comparing new participants of a mobile versus a pharmacy-based needle exchange program Riley ED Safaeian M, Strathdee S, Marx MA, Huettner S, Beilenson P, Vlahov D JAIDS Journal of Acquired Immune Deficiency Syndromes 2000 24 1 57 61 Harm reduction programs in Vilnius, the capital of Lithuania Subata E Kriksciukaityte R HIV/AIDS prevention amongst injecting drug users in Lithuania:Best practices Vilnius, Lithuania , Central and Eastern European Harm Reduction Network LITINTERP 2003 The outreach program for injecting drug users in Rome: Berlin, Germany. De Rugeriis E Patruno F, Arcari P, Zaccarelli M, Paciello T, Barra M 1993 Mobile unit for syringe exchange and condom distribution in a health education program: Berlin, Germany. Colomo C Estebanez P, Merodio C, Fitch K, Munoz M, Garcia Lalinde G 1993 Feasibility in needle exchange programme: an evaluation of a pilot programme in Catania, Sicily Nigro L Casciaro A, Matalone M, Aloisio P, Bruno S, The Unit Operators Group International Journal of Drug Policy 2000 11 299–303 10.1016/S0955-3959(00)00059-1 Evaluating the first syringe exchange program in Paris: Amsterdam, Netherlands. Lhomme JP Edwige A, Ilie C, Regnier AF, Gehant A 1992 Views from the street: Needle exchange Users in Glasgow Glasgow Involvement Group & April Shaw (SDF Research Officer) Glasgow , Scottish Drugs Forum Retrieved May 2006 2005 http://www.sdf.org.uk/sdf/files/Glasgow%20needleexchangestudy.pdf Needle and syringe vending machine trial evaluation report1 Berg R Sydney , NSW Department of Health 1993 Needle and syringe vending machine trial evaluation report 2 Berg R Albury, Sydney , NSW Department of Health 1995 Evaluation of the fitpacks vending machine trial at Kalgoorlie regional hospital, Australia Moloney A Kalgoorlie , Northern Goldfields Health Services Public & Community Health 2001 ACT Syringe vending machines trial 2004-2006 McDonald D Canberra, Australia 2005 Starting and managing needle and syringe programs: a guide for central and eastern Europe and the newly independent states of the former soviet union Burrows D New York , International Harm Reduction Development Derricott APJ 2000 "Lifepoint": A case study in using social science community identification data to guide the implementation of a needle exchange program Somlai AM Kelly JA, Otto-Salaj L, Nelson D AIDS Education and Prevention 1999 11 3 187 202 Needle exchange and difficulty with needle access during an ongoing HIV epidemic Wood E Tyndall MW, Spittal PM, Li K, Hogg RS, O’Shaughnessy MV, Schechter MT International Journal of Drug Policy 2002 13 95 102 10.1016/S0955-3959(02)00008-7 HIV in Bangladesh: The Present Scenario Govt. of Bangladesh A summary of key findings from the fifth round of serological and behaviour surveillance for HIV in Bangladesh (2003-2004) National AIDS/STD Programme, Directorate General of Health Services, Ministry of Health & Family Welfare 2004 HIV transmission risk behaviour of clients attending syringe-exchange schemes in England and Scotland Stimson GV Donoghoe M, Alidritt L, Dolan K British Journal of Addiction 1988 83 1449 1455 10.1111/j.1360-0443.1988.tb02559.x 3233411 Needle Exchange: Saving Lives Fuller J America 1998 179 8 11 Syringe vending machines as a form of needle syringe program: Advantages and Disadvantages Islam MM Conigrave KM Journal of Substance Use 2007 12 3 203 2212 10.1080/14659890701249640 The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings Islam MM Wodak A Conigrave CM International Journal of Drug Policy (in press) 2007 Starting and managing needle and syringe programs: a guide for central and eastern Europe and the newly independent states of the former Soviet Union Burrows D New York , International Harm Reduction Development Derricott APJ 2000 Geographic proximity, policy and utilization of syringe exchange programmes Rockwell R Des Jarlais DC, Friedman SR, Perlis TE, Paone D Aids Care 1999 11 4 437 442 10.1080/09540129947811 10533536 Predictors of Persistent High-Risk Syringe Sharing During an Ongoing HIV Epidemic Wood E Tyndall MW, Spittal P, Li K, Hogg RS, O’Shaughnessy M, Schechter MT Canadian Journal of Infectious Diseases 2001 12 (Suppl. B). Suppl. B Barriers to use of needle and syringe programmes in a high drug use area of Sydney, New South Wales Treloar C Cao W International Journal of Drug Policy 2005 16 308 315 10.1016/j.drugpo.2005.06.005 Social and health impact study: The closure and relocation of the St Marys needle & syringe program Southgate E Blair D, Hopwood M Sydney , National Center in HIV Social Research 2000 Syringe exchanges: A public health response to problem drug use Cox G Lawless M, Cassin SP, Geoghegan TW Irish Medical Journal 2000 93 5 143 146 11072923 Syringe exchange by automat Klaassen R The International Journal of Drug Policy 1989 1 3 6 7 IVDU population of Medecins du Monde's mobile unit. "Syringe exchange": Amsterdam, Netherlands. Edwige A Aeberhard F, Benarosch J, Gehant A, Lhomme JP 1992 BIPS bus itinerant prevention SIDA (mobile AIDS prevention unit) in Geneva (Switzerland) for drug injectors: Amsterdam, Netherlands. Hausser D Mani C, Malatesta D, Joye D 1992 The efficacy of using mobile vans while providing outreach services to high risk substance abusers: Yokohama, Japan. McConnell W Rael M, Hewitt W, Mata A, Austin B 1994 Provision of syringes and prescription of heroin in prison: The Swiss experience in the prisons of Hindelbank and Oberschöngrün Nelles J Dobler-Mikola A, Kaufmann B Harm reduction in prison (pp 239–262) Berne , Peter Lang J Nelles & A Fuhrer 1997 Drug, HIV and hepatitis prevention in the Realta Contonal men’s prison: Summary of the evaluation Nelles J Fuhrer A, Vincenz I Bern , Swiss Federal office of Public Health 1999 Reaching drug users through mobile services for HIV prevention Tsekhanovich A Drug Abuse and HIV/AIDS: Lessons Learned Vienna and Geneva , UNDCP/UNAIDS Hedrich D 2001 35 38 Gender differences in syringe exchange program use in Oslo, Norway Miller M Eskild A, Mella I, Moi H, Magnus P Addiction 2001 96 1639–1651 Outreach work on HIV/AIDS prevention among out-of-treatment injecting drug users Nikolov Z Drug Abuse and HIV/AIDS: Lessons Learned Vienna and Geneva , UNDCP/UNAIDS Hedrich D 2001 16 21 Main tendencies of injecting drug users feature in the mobile units of the programs of outreach syringes exchange programs of Medicos del Mundo: Barcelona, Spain. Estebanez P Arenas MAR, Manez AS, Alvaro JR, Garcia AB 2002 Prevention of blood borne virus infections among drug users in an open prison by syringe vending machines Heinemann A Gross U Sucht 2001 47 1 57 65 'Dropouts' or drop-ins'? Client retention and participation in New Haven's Needle Exchange Program Khoshnood K Kaplan EH, Heimer R Public Health Reports 1995 110 4 462 466 1382156 7638334 Unspoken but ever present: Hepatitis C in a regional setting Fitzgerald J McDonald K, Klugman M Melbourne , Centre for the Study of Health & Society and The Sociology Program, University of Melbourne 2004